Irinolif 100 mg
Rx — Prescription only
Oncology Injectable / Vial
Cytotoxic chemotherapy for gastrointestinal cancers, a topoisomerase I inhibitor, presented as an injection for intravenous infusion.
Composition
Irinotecan Hydrochloride Injection 100 mg / 5 mL
Strength
100 mg / Vial
Pack size
1 Vial
Therapeutic category
Oncology
Indications
Gastrointestinal Cancers
Dosage and directions
For intravenous infusion. To be prescribed, dosed and administered under the supervision of a qualified oncologist. Refer to the approved pack insert for the full prescribing information.
Marketed by
LifeSpark Pharma Private Limited
Manufactured at WHO-GMP approved partner facilities. The
manufacturing plant and licence number are printed on the pack.
Keep out of reach of children.
Products to be used as directed. Read the label carefully. Consult your physician.
To be sold by retail on the prescription of a registered medical practitioner only.
This page is a summary. The pack insert supplied with the product is the authoritative document; where the two differ, the insert prevails. Experienced a side effect? Report it here.
Enquire about Irinolif 100 mg
Please mention the quantity or the information you need. For side effects, use the pharmacovigilance form instead.